Strategy doesn't fail at the analysis. It fails at the decision.
Structural Integrity
Pharma commercial teams have more data and tools than ever. What's missing is a reliable way to convert it into decisions that are defensible, durable, and executable.
High-Conviction Logic
Most platforms help teams move faster. Axonal helps teams decide better. Speed without conviction produces rework, drift, and launches that lose pressure.
Institutional Memory
Axonal gives every commercial decision a structure it can survive in — weighing alternatives and creating a persistent record that travels across teams and time.
Not another analytics layer — the decision infrastructure underneath your commercial operation. This is what it looks like when strategy holds and execution actually follows.
Pharma decisions get reviewed by medical, legal, and regulatory before they go anywhere. They get challenged in brand planning. They get revisited when the market moves. Most AI tools aren't built for that environment. They produce outputs that look right until someone asks a hard question. Axonal is built for the hard question.
Every output shows its work. No black-box conclusions, no recommendations that can't be traced. When a decision gets challenged in a review meeting, you have the evidence and the logic to defend it.
Citations and sources are embedded into every Decision Object — not available on request, built in from the start. Your team doesn't have to go back and reconstruct the case. It's already there.
AI structures the decision. Your team makes it. Control stays where accountability lives — with the people who will be asked to defend the outcome. Axonal is designed to sharpen judgment, not replace it.
HIPAA-aligned. SOC 2-aligned. AES-256 encryption at rest, TLS in transit, org-scoped data isolation, and client-controlled retention. Your data stays in your environment. Full stop.
Every decision, every revision, every action triggered downstream is logged. When a regulator, a medical reviewer, or a new CMO asks what was decided and why, the answer is accessible and complete.
Two objects. One connected system. No gap between what was decided and what gets done.
Most commercial decisions exist in three places simultaneously: a slide nobody revisits, an inbox thread nobody can find, and the memory of the person who was in the room. None of those survive a leadership change, a team handoff, or a regulatory review.
A Decision Object changes that. It is a structured, persistent record of a decision that travels with the decision — not behind it.
Decision Object Metadata
Decision Objects govern what should be done and why.
Action Objects govern how it gets done and by whom.
The connection between them is what closes the gap between strategy and execution — permanently, not meeting by meeting.
Decision in Practice
A specialty pharma team preparing for launch faced a field force prioritization decision with no clean answer. Higher-experience prescribers offered predictability but slower acceleration. Earlier adopters offered speed but higher access and education friction. The wrong call would either cap near-term impact or overwhelm a limited field team at the worst possible moment.
Axonal structured the decision across three dimensions — adoption velocity, access friction, and educational burden — forcing explicit tradeoffs instead of average assumptions. The output wasn't a recommendation. It was a Decision Object: the chosen direction, the conditions under which it held, the signals that would trigger a course correction, and the rationale the team could defend six months later. Field effort aligned to highest-acceleration segments. Risk was managed before the quarter started, not discovered inside it. This is what a Decision Object does in practice. Not analysis. A decision — with everything a team needs to act on it and return to it.
Specialty Pharma · Field Force Strategy
Specialized agents work inside structured workflows. Every output is explainable, reviewable, and logged.
Finds, filters, and cites the most relevant internal and external evidence.
Synthesizes signals, tests scenarios, and surfaces implications.
Packages outputs into decision and action objects that persist and scale.
Axonal deploys through structured engagements built around the decisions that matter most. Each pack delivers a defined set of Decision Objects — with the evidence, rationale, and execution guidance to act on them.
For brands preparing to enter the market. Five Decision Objects covering positioning, messaging, competitive response, field prioritization, and market access strategy.
Cost & Delivery
Delivered in four to six weeks starting at $100K
For in-market brands facing competitive pressure or evolving evidence. Five Decision Objects: competitive response, evidence strategy, narrative momentum, market risk, and signal monitoring.
Cost & Delivery
Delivered in four to six weeks from $60K to $100K
For teams facing a specific market event (a competitor readout, a label update, a congress moment) that demands a defensible decision inside 48 hours.
Cost & Delivery
$15K to $30K per event, annual monitoring from $120K to $250K